Our team participated in ECTRIMS 2025, the European Committee for Treatment and Research in Multiple Sclerosis congress – the world’s largest MS neurology conference held in Barcelona. We showcased our “Gait Lab in a Shoe” platform in our booth in the exhibit hall - bringing laboratory-grade gait analysis into everyday clinical practice at a fraction of the cost. In addition, our research team published the latest results from our clinical trial activities.
We were joined by senior neurologists from our Scientific Advisory Board and world-class gait specialists from our team of Human Kinetics PhDs, as we showcased how our gait monitoring platform can transform MS research and care.
Our key takeaway? There’s growing consensus that real-world gait data can transform both MS research and clinical care, detecting changes months earlier than standard measures, and delivering more sensitive trial endpoints. The momentum is clear, and we’re excited to continue building partnerships that bring this innovation into practice.
